Moving Care Forward in Advanced Gastric Cancer: What, When, and in Whom

Access Course

 

Moving Care Forward in Advanced Gastric Cancer: What, When,and in WhomExperts discuss the emerging research into the use of checkpoint inhibitors in gastric and GE junction cancers

 

This activity is intended for oncologists, gastroenterologists, nurses, and other healthcare professionals who manage patients with gastric cancer.

 

The goal of this activity is to discuss the emerging role of immunotherapy in patients with gastric and gastroesophageal junction cancers.

 

 

Approximate Time to Complete: 45 minutes

 

 

Credit Available: Mar. 26, 2019 - Mar. 26, 2020

 

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Have increased knowledge regarding the emerging clinical trial data on the management of gastric cancer
  • Have greater competence related to selecting the most appropriate treatment regimen in patients with gastric cancer through the continuum of care
  • Have greater competence related to managing treatment-related adverse events in patients with gastric cancer
Accreditation Council for Continuing Medical Education (non-MD/DO)
AMA PRA Category 1 Credit(s)™: 0.50
American Board of Internal Medicine
ABIM MOC Part 2 Credits: 0.50